How big is the Global Influenza Diagnostics Market?

The Global Influenza Diagnostics Market size is expected to reach USD 1.09 billion in 2024 and grow at a CAGR of 5.60% to reach USD 1.43 billion by 2029. Read More

What is the current Global Influenza Diagnostics Market size?

In 2024, the Global Influenza Diagnostics Market size is expected to reach USD 1.09 billion. Read More

Who are the key players in Global Influenza Diagnostics Market?

Abbott, Becton, Dickinson and Company , F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific and DiaSorin Molecular are the major companies operating in the Global Influenza Diagnostics Market. Read More

Which is the fastest growing region in Global Influenza Diagnostics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Influenza Diagnostics Market?

In 2024, the North America accounts for the largest market share in Global Influenza Diagnostics Market. Read More

What years does this Global Influenza Diagnostics Market cover, and what was the market size in 2023?

In 2023, the Global Influenza Diagnostics Market size was estimated at USD 1.03 billion. The report covers the Global Influenza Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Influenza Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Influenza Diagnostics Market Share

Statistics for the 2023 & 2024 Global Influenza Diagnostics market share, created by Mordor Intelligence™ Industry Reports. Global Influenza Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Influenza Diagnostics Industry

The influenza diagnostics market is highly competitive and consists of several significant players. In terms of market share, few major players currently dominate the market. Companies like Coris BioConcept, DiaSorin SpA, F. Hoffmann-La Roche AG, Meridian Bioscience Inc., Quidel Corporation, and Sekisui Diagnostics others, hold a substantial share in the market.